Acadia Healthcare (NASDAQ:ACHC) Price Target Raised to $33.00

Acadia Healthcare (NASDAQ:ACHC) had its price objective lifted by Leerink Partners from $30.00 to $33.00 in a report released on Wednesday morning, Marketbeat reports. They currently have a market perform rating on the stock.

Other equities analysts also recently issued research reports about the stock. KeyCorp boosted their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Barclays raised their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. UBS Group increased their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. Finally, Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus target price of $30.69.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $28.09 on Wednesday. The stock has a 50-day moving average price of $29.74 and a 200 day moving average price of $27.34. The stock has a market capitalization of $2.62 billion, a P/E ratio of -2.26, a P/E/G ratio of 8.95 and a beta of 0.62. Acadia Healthcare has a 12-month low of $11.43 and a 12-month high of $35.83. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. During the same period in the previous year, the firm earned $0.83 EPS. The firm’s revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities research analysts forecast that Acadia Healthcare will post 1.55 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently bought and sold shares of the business. BlackRock Inc. bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth about $441,685,000. Jefferies Financial Group Inc. bought a new position in shares of Acadia Healthcare in the 2nd quarter valued at about $106,458,000. Vaughan Nelson Investment Management L.P. purchased a new position in Acadia Healthcare in the first quarter worth about $43,017,000. Deutsche Bank AG purchased a new position in Acadia Healthcare in the second quarter worth about $49,746,000. Finally, Invenomic Capital Management LP increased its stake in Acadia Healthcare by 71.0% during the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after acquiring an additional 1,375,647 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.

Acadia’s facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.